Akreos IOLRecalls & reported problems across all models
Bausch & Lomb Incorporated · 8 models in the FDA device registry
Data updated Oct 16, 2026 from official FDA records · Editorial policy
1 open recall names at least one Akreos IOL model. Check whether yours is affected in the recall details, and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 10
- Deaths reported
- 0
- Injuries reported
- 10
- Recalls
- 1
We found 8 models of Akreos IOL by Bausch & Lomb Incorporated in the FDA's device registry (GUDID). Together they are named in 10 adverse event reports in the FDA's MAUDE database, received between Apr 14, 2023 and Jun 18, 2026 — classified as 10 injuries.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (3 reports).
1 FDA recall record name at least one of these models by its device identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event. Widely used products collect more reports, so totals can't be used to compare products or estimate failure rates. Only reports that name a model's exact device identifier are counted. What reports can and can't tell you · How this data works
Reports received per month, all models
Akreos IOL recalls
FDA recall records that name at least one of these models by its device identifier, newest first. Each recall usually covers specific models or lots, so check the details.
- Jun 6, 2025Open, Classified
An off-power error was identified, which resulted in a diopter of 16, rather than the intended 3 diopter. Implantation of affected intraocular lens could result in functional visual impairment or reduction in visual acuity which could result in the need for optical or surgical correction.
Z-2451-2025 · Root cause: Process control · Recall details · FDA record ↗
Most reported Akreos IOL problems
Device problems
- Adverse Event Without Identified Device or Use Problem5
- Device Dislodged or Dislocated3
- Insufficient Device Problem Information2
- Calcified1
- Ejection Problem1
- Material Twisted/Bent1
Patient problems
- Insufficient Information4
- Capsular Bag Tear3
- Blurred Vision1
- Calcium Deposits/Calcification1
- Corneal Edema1
- Endophthalmitis1
- Eye Pain1
- Hypopyon1
Akreos IOL models
8 models, most reported first. Each model has its own page with its reports, recalls and device details.
- Akreos® IOL AO60Intraocular Lens1 recall0 reports
- Akreos® IOL AO60Intraocular Lens4 reports
- Akreos® IOL AO60Intraocular Lens1 report
- Akreos® IOL AO60Intraocular Lens1 report
- Akreos® IOL AO60Intraocular Lens1 report
- Akreos® IOL AO60Intraocular Lens1 report
- Akreos® IOL AO60Intraocular Lens1 report
- Akreos® IOL AO60Intraocular Lens1 report
Recent Akreos IOL adverse event reports
The 10 most recent reports across all models, in the reporter's own words as published by the FDA.
InjuryJun 18, 2026Insufficient Device Problem Information
IT WAS REPORTED THAT 4 DAYS AFTER IMPLANTATION OF AN INTRAOCULAR LENS (IOL) IN THE LEFT EYE (OS), THE PATIENT PRESENTED COMPLAINING OF VISION LOSS AND EYE PAIN. SLIT LAMP EXAMINATION IDENTIFIED A FIBRIN REACTION WITH HYPOPYON. BASED ON THE FINDINGS THE SURGEON CONCLUDED THE CAUSE AS ENDOPHTHALMITIS. TWO DAYS LATER, THE PATIENT WAS EVALUATED BY A RETINA SPECIALIST WHO NOTED THE VIEW OF POSTERIOR SEGMENT WAS LIMITED DUE TO VITREOUS OPACITY. A VITREOUS TAP WAS PERFORMED, AND AN INJECTION OF VANCOMYCIN AND CEFTAZIDIME WAS ADMINISTERED. THE PATIENT'S BEST CORRECTED VISUAL ACUITY (BCVA) DECREASED TO HAND MOTION. IN THE IMPLANTING SURGEON'S OPINION, THE MOST LIKELY CAUSE OF THE EVENT COULD NOT BE DETERMINED. THE PATIENT¿S OUTCOME IS UNKNOWN, AS THEY HAVE NOT RETURNED FOR FOLLOW-UP AND CANNOT BE REACHED. THE FOLLOWING MEDICATIONS WERE PRESCRIBED FOR USE AT HOME POST-OPERATIVELY: PREDNISOLONE 1%: 1 GTT QID X 2 WEEKS, THEN TID X 2 WEEKS (TOTAL DURATION: 1 MONTH), OFLOXACIN 0.3%: 1 GTT QID X 7 DAYS, KETOROLAC 0.5%: 1 GTT QID X 2 WEEKS, THEN TID X 2 WEEKS (TOTAL DURATION: 1 MONTH).
Patient problems: Endophthalmitis; Eye Pain; Hypopyon; Loss of Vision; Vitreous Floaters
MAUDE report 25551289 ↗InjuryOct 28, 2025Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT APPROXIMATELY 7 WEEKS AFTER IMPLANTATION OF AN INTRAOCULAR LENS (IOL) INTO THE LEFT EYE (OS), THE LENS WAS EXCHANGED WITH A DIFFERENT MODEL IOL DUE TO DISLOCATION. ADDITIONAL INFORMATION WAS REQUESTED BUT NOT RECEIVED.
Patient problems: Insufficient Information
MAUDE report 23407413 ↗InjuryAug 29, 2025Calcified; Device Dislodged or Dislocated; Calcified; Device Dislodged or Dislocated
IT WAS REPORTED THAT APPROXIMATELY 6 YEARS AFTER IMPLANTATION OF AN INTRAOCULAR LENS (IOL), THE PATIENT NOTICED A DECREASE OF VISION AND FUZZINESS IN THEIR LEFT EYE. THE SURGEON'S FINDINGS WERE A CALCIFIED LENS WITH AGAINST THE RULE ASTIGMATISM. APPROXIMATIVELY 4 MONTHS LATER, THE LENS WAS EXCHANGED FOR A DIFFERENT MODEL IOL DUE TO DISLOCATION. A VITRECTOMY WAS PERFORMED DUE TO VITREOUS STRANDS. IN THE SURGEON¿S OPINION THE LIKELY CAUSE OF THE IOL DISLOCATION WAS THE CALCIFICATION OF THE LENS. THE PATIENT¿S OUTCOME IS GOOD.
Patient problems: Blurred Vision; Calcium Deposits/Calcification; Visual Disturbances
MAUDE report 22923215 ↗InjuryMay 23, 2025Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information
IT WAS REPORTED THAT APPROXIMATELY TWO MONTHS AFTER IMPLANTATION OF AN INTRAOCULAR LENS (IOL) INTO THE RIGHT EYE (OD), THE LENS WAS EXCHANGED FOR A DIFFERENT MODEL IOL DUE TO MECHANICAL BREAKDOWN OF THE INITIAL LENS. ADDITIONAL INFORMATION WAS REQUESTED BUT NOT RECEIVED.
Patient problems: Insufficient Information
MAUDE report 22077479 ↗InjuryApr 22, 2025Device Dislodged or Dislocated; Device Dislodged or Dislocated
IT WAS REPORTED THAT APPROXIMATELY 5 WEEKS AFTER THE IMPLANTATION OF AN INTRAOCULAR LENS (IOL) INTO THE RIGHT EYE (OD), THE LENS WAS EXCHANGED WITH A DIFFERENT MODEL IOL AFTER DISLOCATING. ADDITIONAL INFORMATION WAS REQUESTED BUT NOT RECEIVED.
Patient problems: Insufficient Information
MAUDE report 21886666 ↗InjuryMay 7, 2024Material Twisted/Bent; Ejection Problem; Material Twisted/Bent; Ejection Problem
IT WAS REPORTED THAT DURING IMPLANTATION OF AN INTRAOCULAR LENS (IOL), THE LENS CAME OUT OF CARTRIDGE TWISTED AND STUCK ON PLUNGER. THE INCISION WAS ENLARGED, AN ANTERIOR VITRECTOMY WAS PERFORMED, AND AN ANTERIOR CHAMBER IOL WAS IMPLANTED. SUTURES WERE REQUIRED. PATIENT PROGNOSIS IS GOOD. PATIENT HAS NOT YET RECOVERED, STILL HAS CORNEAL EDEMA. ADDITIONAL INFORMATION WAS REQUESTED, BUT NOT RECEIVED.
Patient problems: Corneal Edema; Insufficient Information
MAUDE report 19260668 ↗InjuryJan 24, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
REPORTEDLY, THERE WAS INSUFFICIENT CAPSULAR SUPPORT. A VITRECTOMY WAS PERFORMED, AND A LENS OF A DIFFERENT MODEL WAS PLACED IN THE ANTERIOR CHAMBER. ADDITIONAL INFORMATION WAS REQUESTED BUT NOT RECEIVED.
Patient problems: Capsular Bag Tear
MAUDE report 18576330 ↗InjuryJan 24, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
REPORTEDLY, THERE WAS INSUFFICIENT CAPSULAR SUPPORT. A VITRECTOMY WAS PERFORMED, AND A LENS OF A DIFFERENT MODEL WAS PLACED IN THE ANTERIOR CHAMBER. ADDITIONAL INFORMATION WAS REQUESTED BUT NOT RECEIVED.
Patient problems: Capsular Bag Tear
MAUDE report 18576298 ↗InjuryAug 23, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT DURING IMPLANTATION OF THE IOL IN THE LEFT EYE VITREOUS LYSIS OCCURRED. THE IOL WAS REMOVED, A VITRECTOMY WAS PERFORMED, AND ANOTHER LENS OF A DIFFERENT DIOPTER WAS PLACED. PATIENT OUTCOME IS UNKNOWN. ADDITIONAL INFORMATION WAS REQUESTED BUT NOT RECEIVED.
Patient problems: Vitreous Loss
MAUDE report 17604171 ↗InjuryApr 14, 2023Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT AFTER THE IMPLANTATION OF AN INTRAOCULAR LENS (IOL) INTO THE RIGHT EYE (OD), THE CAPSULAR BAG BECAME UNSTABLE AND BROKE. THE IOL WAS CUT AND REMOVED FROM EYE, AND A SUCCESSFUL INTRAOPERATIVE LENS REPLACEMENT USING A LENS OF AN UNKNOWN MODEL WAS COMPLETED. THE PATIENT'S OUTCOME IS GOOD.
Patient problems: Capsular Bag Tear
MAUDE report 16743044 ↗
Other Bausch & Lomb Incorporated products
- enVista IOL74 models · 70 reports · 1 recall
- enVista Toric IOL450 models · 15 reports · 2 recalls
- enVista Envy IOL53 models · 52 reports · 1 recall
- enVista Envy Toric IOL513 models · 39 reports · 1 recall
- enVista Aspire IOL57 models · 10 reports · 1 recall
- enVista Aspire Toric IOL513 models · 8 reports · 1 recall
- IC-8 Apthera IOL20 models · 38 reports
- SofPort IOL20 models · 29 reports
Sources and updates
- Models: FDA GUDID, file dated Oct 13, 2026. Models are grouped by the brand name the manufacturer registered.
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page